$700.33
0.000.00%
Pre-Market: Feb 21, 4:02 PM EDT
Comments
Loading...
Latest news for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock
Regeneron Pharmaceuticals Stock (NASDAQ: REGN)
Categories: All
Friday, February 21, 2025
Tuesday, February 18, 2025
Monday, February 17, 2025
Friday, February 14, 2025
Tuesday, February 11, 2025
Monday, February 10, 2025
Friday, February 07, 2025
Thursday, February 06, 2025
Wednesday, February 05, 2025
Tuesday, February 04, 2025
- US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
- Regeneron Pharma Q4 Earnings Crush Estimates, Initiates Dividend And Additional Stock Buyback Program
- Regeneron shares are trading higher after the...
- Regeneron Board Authorized Additional $3B Sha...
- Regeneron Sees 2025 Non-GAAP Gross Margin On ...
- Regeneron Pharmaceuticals Q4 2024 Adj. EPS $1...
- Earnings Scheduled For February 4, 2025
Tuesday, January 28, 2025
Monday, January 27, 2025
Friday, January 24, 2025
Thursday, January 16, 2025
Tuesday, January 14, 2025
Monday, January 13, 2025
Friday, January 10, 2025
Thursday, January 09, 2025
Wednesday, January 08, 2025
Tuesday, January 07, 2025
Monday, January 06, 2025
Thursday, January 02, 2025
Monday, December 23, 2024
Sunday, December 22, 2024
Thursday, December 19, 2024
Tuesday, December 17, 2024
- Regeneron Pharmaceuticals shares are trading ...
- Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
- Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
- What 25 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
- Regeneron Says Primary Endpoint Was Met In Ph...